Literature DB >> 29055016

SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.

Arturo Orlacchio1, Michela Ranieri1, Martina Brave1, Valeria Antico Arciuch1, Toni Forde1, Daniela De Martino1, Karen E Anderson2, Phillip Hawkins2, Antonio Di Cristofano3.   

Abstract

Activation of the PI3K-AKT signaling cascade is a common critical event during malignant transformation. In this study, we used thyroid gland epithelial cells and a series of genetically engineered mouse strains as model systems to demonstrate that, although necessary, AKT activation is not sufficient for PI3K-driven transformation. Instead, transformation requires the activity of the PDK1-regulated AGC family of protein kinases. In particular, SGK1 was found to be essential for proliferation and survival of thyroid cancer cells harboring PI3K-activating mutations. Notably, cotargeting SGK1 and AKT resulted in significantly higher growth suppression than inhibiting either PI3K or AKT alone. Overall, these findings underscore the clinical relevance of AKT-independent pathways in tumors driven by genetic lesions targeting the PI3K cascade. Cancer Res; 77(24); 6914-26. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055016      PMCID: PMC5732884          DOI: 10.1158/0008-5472.CAN-17-2105

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.

Authors:  Pengda Liu; Wenjian Gan; Y Rebecca Chin; Kohei Ogura; Jianping Guo; Jinfang Zhang; Bin Wang; John Blenis; Lewis C Cantley; Alex Toker; Bing Su; Wenyi Wei
Journal:  Cancer Discov       Date:  2015-08-20       Impact factor: 39.397

Review 2.  PI3K signaling in cancer: beyond AKT.

Authors:  Evan C Lien; Christian C Dibble; Alex Toker
Journal:  Curr Opin Cell Biol       Date:  2017-03-24       Impact factor: 8.382

3.  Establishment and characterization of cell lines from a novel mouse model of poorly differentiated thyroid carcinoma: powerful tools for basic and preclinical research.

Authors:  Mariavittoria Dima; Kelly A Miller; Valeria Gabriela Antico-Arciuch; Antonio Di Cristofano
Journal:  Thyroid       Date:  2011-07-18       Impact factor: 6.568

4.  A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

Authors:  Yiqun Zhang; Patrick Kwok-Shing Ng; Melanie Kucherlapati; Fengju Chen; Yuexin Liu; Yiu Huen Tsang; Guillermo de Velasco; Kang Jin Jeong; Rehan Akbani; Angela Hadjipanayis; Angeliki Pantazi; Christopher A Bristow; Eunjung Lee; Harshad S Mahadeshwar; Jiabin Tang; Jianhua Zhang; Lixing Yang; Sahil Seth; Semin Lee; Xiaojia Ren; Xingzhi Song; Huandong Sun; Jonathan Seidman; Lovelace J Luquette; Ruibin Xi; Lynda Chin; Alexei Protopopov; Thomas F Westbrook; Carl Simon Shelley; Toni K Choueiri; Michael Ittmann; Carter Van Waes; John N Weinstein; Han Liang; Elizabeth P Henske; Andrew K Godwin; Peter J Park; Raju Kucherlapati; Kenneth L Scott; Gordon B Mills; David J Kwiatkowski; Chad J Creighton
Journal:  Cancer Cell       Date:  2017-05-18       Impact factor: 31.743

5.  The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.

Authors:  R M Biondi; A Kieloch; R A Currie; M Deak; D R Alessi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

6.  Renal function of gene-targeted mice lacking both SGK1 and SGK3.

Authors:  Florian Grahammer; Ferruh Artunc; Diana Sandulache; Rexhep Rexhepaj; Björn Friedrich; Teut Risler; James A McCormick; Kevin Dawson; Jian Wang; David Pearce; Peer Wulff; Dietmar Kuhl; Florian Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04       Impact factor: 3.619

7.  In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.

Authors:  Barry J Collins; Maria Deak; J Simon C Arthur; Laura J Armit; Dario R Alessi
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression.

Authors:  Devora Champa; Marika A Russo; Xiao-Hui Liao; Samuel Refetoff; Ronald A Ghossein; Antonio Di Cristofano
Journal:  Endocr Relat Cancer       Date:  2014-07-10       Impact factor: 5.678

9.  First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors.

Authors:  Debashis Sarker; Joo Ern Ang; Richard Baird; Rebecca Kristeleit; Krunal Shah; Victor Moreno; Paul A Clarke; Florence I Raynaud; Gallia Levy; Joseph A Ware; Kathryn Mazina; Ray Lin; Jenny Wu; Jill Fredrickson; Jill M Spoerke; Mark R Lackner; Yibing Yan; Lori S Friedman; Stan B Kaye; Mika K Derynck; Paul Workman; Johann S de Bono
Journal:  Clin Cancer Res       Date:  2014-11-04       Impact factor: 12.531

10.  Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.

Authors:  Valeria G Antico Arciuch; Marika A Russo; Mariavittoria Dima; Kristy S Kang; Florence Dasrath; Xiao-Hui Liao; Samuel Refetoff; Cristina Montagna; Antonio Di Cristofano
Journal:  Oncotarget       Date:  2011-12
View more
  12 in total

1.  Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.

Authors:  Matthew Dean; Vivian Jin; Angela Russo; Daniel D Lantvit; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

2.  Estrogen-increased SGK1 Promotes Endometrial Stromal Cell Invasion in Adenomyosis by Regulating with LPAR2.

Authors:  Guangzheng Zhong; Qingxue Zhang; Yingchen Wu; Hao Wang; Yi Li; Yangzhi Li; Yihua Liang
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 2.924

3.  Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.

Authors:  H Yin; X Zheng; X Tang; Z Zang; B Li; S He; R Shen; H Yang; S Li
Journal:  J Endocrinol Invest       Date:  2021-02-09       Impact factor: 4.256

4.  An integrated approach to infer cross-talks between intracellular protein transport and signaling pathways.

Authors:  Kumar Parijat Tripathi; Marina Piccirillo; Mario Rosario Guarracino
Journal:  BMC Bioinformatics       Date:  2018-03-08       Impact factor: 3.169

Review 5.  The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star.

Authors:  Ruizhe Zhu; Gang Yang; Zhe Cao; Kexin Shen; Lianfang Zheng; Jianchun Xiao; Lei You; Taiping Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-07-15       Impact factor: 8.168

6.  SGK1 Attenuates Oxidative Stress-Induced Renal Tubular Epithelial Cell Injury by Regulating Mitochondrial Function.

Authors:  Daofang Jiang; Chensheng Fu; Jing Xiao; Zhenxing Zhang; Jianan Zou; Zhibin Ye; Xiaoli Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-09-18       Impact factor: 6.543

Review 7.  Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.

Authors:  Ilaria Guerriero; Gianni Monaco; Vincenzo Coppola; Arturo Orlacchio
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-22

8.  Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients.

Authors:  Laura Stertz; Jessica Di Re; Guangsheng Pei; Gabriel R Fries; Emily Mendez; Shenglan Li; Laura Smith-Callahan; Henriette Raventos; Jerricho Tipo; Rohan Cherukuru; Zhongming Zhao; Ying Liu; Peilin Jia; Fernanda Laezza; Consuelo Walss-Bass
Journal:  Neuropsychopharmacology       Date:  2020-12-07       Impact factor: 7.853

Review 9.  The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.

Authors:  Daniel J Turnham; Nicholas Bullock; Manisha S Dass; John N Staffurth; Helen B Pearson
Journal:  Cells       Date:  2020-10-22       Impact factor: 6.600

10.  ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma.

Authors:  Zhuoyu Gu; Liping Wang; Xiaohan Yao; Qian Long; Kaping Lee; Jieyao Li; Dongli Yue; Shuangning Yang; Yanfen Liu; Na Li; Yixin Li
Journal:  Cell Death Dis       Date:  2020-10-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.